Alert detail

LCD L37832: MolDX: Breast Cancer Index® (BCI) Gene Expression Test — CGS

Policy ID: LCD-L37832Specialty: OncologyAdded: 6/5/2026Effective: October 23, 2025lcd
Routine

What changed

New BCI test coverage effective 10/23/2025 impacts billing.

Who’s affected: Oncology billing teams · Effective: October 23, 2025

Affected codes

Codes81518

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 4 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.